2014 annual financial data
TG Therapeutics 2014 Net margin
Direct answer
Net margin was -36,606.45%.
Operating income was -55,721,092 USD and net income was -55,781,277 USD.
Operating cash flow was -35,059,919 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 152,381 USD
- Operating income
- -55,721,092 USD
- Net income
- -55,781,277 USD
- Operating cash flow
- -35,059,919 USD